OmniAb, Inc. SEC filings OABI
OmniAb, Inc. has 387 filings in SEC EDGAR's recent list, going back to Mar 19, 2021. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Oct 30, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 30, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 25, 2025 | Aug 24, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 21, 2025 | Apr 18, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 1, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 1, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2023 | Jun 23, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Other events
|
Mar 31, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Other events
|
Nov 18, 2022 | Nov 18, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2022 | Nov 15, 2022 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Nov 14, 2022 | Nov 1, 2022 |
| 8-K/A |
Amended current report
Auditor change, Bylaw or fiscal year change, Other events
|
Nov 7, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change
|
Nov 7, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Oct 24, 2022 | Oct 24, 2022 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Aug 25, 2022 | Aug 22, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2022 | Jun 21, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 24, 2022 | Mar 23, 2022 |
| 8-K |
Current report
Other events
|
Mar 23, 2022 | Mar 23, 2022 |
| 8-K |
Current report
New debt
|
Mar 14, 2022 | Mar 14, 2022 |
| 8-K/A |
Amended current report
Other events
|
Jan 28, 2022 | Aug 12, 2021 |
| 8-K |
Current report
Restatement
|
Dec 1, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Other events
|
Sep 27, 2021 | Sep 27, 2021 |
| 8-K |
Current report
Other events
|
Aug 18, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Other events
|
Aug 12, 2021 | Aug 9, 2021 |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- OABI (Nasdaq), OABIW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Emeryville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1846253
- Former names
- Avista Public Acquisition Corp. II (until Nov 1, 2022)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.